Skip to main content

Medicines and Healthcare Products Regulatory Agency: Finance

Volume 475: debated on Wednesday 7 May 2008

To ask the Secretary of State for Health what the budget of the Medicines and Healthcare products Regulatory Authority is for 2008-09; and how much of this is provided (a) by central Government and (b) by pharmaceutical companies. (202388)

The Medicines and Healthcare products Regulatory Agency's (MHRA's) operating income budget for 2008-09 is £97.9 million.

Of the total income, £11.1 million is provided by the Department to fund the MHRA's work in the regulation of medical devices.

The MHRA is a trading fund and the majority of its income is generated by fees for its medicines regulatory work which are mostly, but not exclusively, charged to the pharmaceutical industry. It monitors costs against fees charged and reviews its fee levels annually. Fees are set, in accordance with HM Treasury guidelines, with a view to achieving cost recovery for each activity for which it sets a charge. The MHRA is also expected to make a return of 3.5 per cent. of average capital employed paid as dividends to HM Treasury via the Department. For 2008-09 the MHRA's trading income budget is £86.8 million.